A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

More than one million people in England have been urged to get vaccines for respiratory syncytial virus (RSV), with health ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

Health officials are urging older adults to get vaccinated against respiratory syncytial virus (RSV). NHS England announced ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

The NHS is urging around 1.3 million older people who have not yet had the respiratory syncytial virus vaccine to get jabbed, as health service chiefs warn it is “not just a winter illness”. Invites ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Health officials have warned that people need to be protected against respiratory syncytial virus (RSV) by the vaccine.

Indiana flu activity reaches 'very high' rates with visits to emergency rooms, urgent care centers and primary care offices ...

Hundreds of thousands of older people in the South East will receive RSV vaccine invites. The NHS is urging those aged 75-79, or who turned 80 after September 1, 2024, to book their vaccination ...

More than one million people in England have been urged to get vaccines for respiratory syncytial ... warning that the virus is ‘not just a winter illness’. While RSV infections are common ...